Skip to main content

GOLDMAN SACHS GROUP INC

Position in RZLT — Rezolute, Inc.

CIK 886982 NEW YORK, NY

Position in RZLT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,837,002
-$1,242,282 QoQ
Shares Held
602,296
-53.8% QoQ
Ownership
0.625%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RZLT Over Time

Shares Held

Position Value (USD)

Derivatives in RZLT

reported options exposure · as of Dec 31, 2025
CallValue
$59,000
CallShares
25,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. RZLT ranks #227 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RZLT

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,837,002 602,296
2025-12-31 $3,079,284 1,304,782
2025-12-31 $59,000 25,000
2025-09-30 $5,089,977 541,487
2025-06-30 $147,643 33,104
2025-03-31 $685,005 236,209